Introduction
The group of pyrido[1,2-a]pyrimidin-4-ones is a well-known class of aza-bridgehead fused heterocyclic compounds which have miscellaneous pharmaceutical applications [1] . For example, this structural pattern is present in the known psychotropic agents risperidone and paliperidone [2, 3] , the human leukocyte elastase inhibitor SSR-69071 [4] , the antiallergic agent ramastine [5] , and the antioxidants 2-arylpyrido[1,2-a]pyrimidin-4-ones [6] (Figure 1 ).
As a continuation to our previous work [7] , we utilized ethyl [(4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)oxy]acetate (1) to obtain novel bi-heterocyclic ethers which are of expected antipsychotic activity. This expected biological activity may back to presence of pyridopyrimidinone and other known biologically active heterocycle such as pyrazole, imidazole, triazole, oxadiazole, pyrone, coumarin, and quinolinone in one-molecular frame [8, 9] . 
Results and Discussion
The chemistry of carboxylic acids and their hydrazides is very interesting due to capability of both carboxylic and hydrazide functions to be transformed to different azoles and azines [10] . This promoted us to convert the readily available ester 1 [7] to its corresponding free acid and acid hydrazide and thence use of both to obtain the claimed heterocycles. Saponification of the ester 1 smoothly furnished the corresponding 2-substituted acetic acid derivative 2. The acetohydrazide 3 was obtained from the hydrazinolysis of the ester 1 (Scheme 1). 
Experimental Section

General
Melting points were determined in open capillary tubes on a digital Gallen-Kamp MFB-595. IR spectra were taken on a Perkin-Elmer FT-IR 1650, using samples in KBr disks. 1 H NMR spectra were recorded on Varian Gemini-200 spectrometer (200 MHz), using DMSO-d 6 as the solvent and TMS as internal reference. Mass spectra were determined on a Shimadzu GC-MS-QP 1000 EX instrument by direct inlet, operating at 70 eV. Elemental microanalyses were performed on a Perkin Elmer CHN-2400 Analyzer. The preparation of ester 1 was previously described [7] and the aldehyde 5 was obtained according to literature [13] . Analytical and spectral data are listed in Tables 1 and 2 , respectively. 
[(4-Oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)oxy]acetic Acid (2)
A solution of the ester 1 (10 mmol) in ethanol (10 mL) was treated with potassium hydroxide aqueous solution (15 mL, 2M). Then the reaction mixture was warmed at 60-70 o C for 4h, left to cool and diluted with cold water (15 mL). The clear solution was adjusted to pH ≈ 6.5 by addition of dilute hydrochloric acid. After cooling in an ice-bath for 2 h, the white precipitates that formed and was collected by filtration to give the acid 2.
[(4-Oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)oxy]acetohydrazide (3)
To a suspension of the compound 1 (10 mmol) in absolute ethanol (25 mL), was added hydrazine hydrate (20 mmol, 98 %). The mixture was stirred at 50-60 o C for 1 h, and then the solid precipitate so formed was filtered and crystallized to afford the hydrazide 3.
2-(2-Oxo-2H-chromen-3-yloxy)-4H-pyrido[1,2-a]pyrimidin-4-one (6), 3-(4-Oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxy)pyrano[2,3-d]pyrido[1,2-a]pyrimidine-2,5-dione (7), and 6-
Methyl-3-(4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxy)-2H-pyrano[3,2-c]quinoline-2,5(6H)-dione (8) General Procedure
Equimolar amounts (10 mmol) of the acetate ester 1 and the proper ohydroxyaldehyde compound namely; salicylaldehyde or 2-hydroxy-4H-pyrido[1,2-a]-pyrimidine-3-carboxaldehyde (4), or 4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxaldehyde (5), in absolute ethanol (50 mL) containing piperidine (0.2 mL) were heated under reflux for 4-5 h. The crystalline products, which were obtained during the course of the reaction, was filtered while hot and crystallized to give the corresponding pyrones 6, 7 and 8.
Ethyl 4-Oxo-4H-furo[2,3-d]pyrido[1,2-a]pyrimidine-2-carboxylate (9)
A mixture of the ester 1 (5 mmol), triethyl orthoformate (6 mmol) and DMF (15 mL) was added and heated in a conical flask at 110-120 o C for 30 min, then the temperature was raised to 140-150 o C gradually over 30 min. After that the mixture was cooled to room temperature and kept in an ice-cold water bath for ca. 2 h. The Yellowish orange crystalline product was filtered and crystallized to give the ester 9. 
2-[(4/5-Methyl-4,5-dihydro-1H-imidazol-2-yl)methoxy]-4H-pyrido-[1,2-a]pyrimidin-4-one (10)
Procedure A.
A mixture of the ester 1 (3 mmol) and 1,2-diaminopropane (3 mmol) was heated without solvent at 180-200 o C for 30 min. Then the mixture was left to cool. The solid product that formed was crystallized to give the imidazoline 10.
Procedure B.
A mixture of the acid 2 (3 mmol) and 1,2-diaminopropane (3 mmol) was heated without solvent at 180-200 o C for 30 min. Then the mixture was left to cool. The solid product that formed was crystallized to give the imidazoline 10.
2-[(1H-Benzimidazol-2-yl)methoxy]-4H-pyrido[1,2-a]pyrimidin-4-one (11), 2-[(Benzoxazol-
2-yl)methoxy]-4H-pyrido[1,2-a]pyrimidin-4-one (12), and 2-[(Benzothiazol-2-yl)methoxy]-
4H-pyrido[1,2-a]pyrimidin-4-one (13)
General Procedure A mixture of the acid 2 (3 mmol) and 1,2-phenylenediamine, or 2-aminophenol, or 2-aminothiophenol (3 mmol) was heated without solvent at 180-200 o C for 30 min. Then the mixture was left to cool. The solid product that formed was crystallized to give the benodiazoles 11-13.
2-[(4-Amino-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methoxy]-4H-pyrido[1,2-a]pyrimidin-4-one (14)
A mixture of the acid 2 (5 mmol) and thiocarbodihydrazide (5 mmol) was heated in absence of solvent at fusion temperature for 15 min. Afterwards, the obtained melt was triturated with cold methanol (10 mL) and the solidified product was filtered, washed with methanol and diethyl ether then crystallized to afford the triazole 14.
Procedure B.
To a solution of the acetohydrazide 3 (5 mmol) in ethanol (50 mL, 95 %), fine divided potassium hydroxide (10 mmol) was added followed by drop-wise addition of carbon disulfide (5 mmol) with continuous stirring at 0-5 o C. After complete addition (ca. 20 min), the reaction mixture was stirred for additional 30 min at room temperature, then the obtained yellow precipitate was diluted with water till complete dissolution and hydrazine hydrate (5 mmol) was added. Then the reaction mixture was boiled until the deep greenish brown coloration persisted and left to cool in a crushed-ice bath. The fine crystals so formed were filtered and crystallized to furnish the triazole 14.
2-[(3-Oxo-2,3-dihydro-1H-pyrazol-4-yl)oxy]-4H-pyrido[1,2-a]-pyrimidin-4-one (15)
To a solution of the acetohydrazide 3 (5 mmol) in DMF (15 mL), triethyl orthoformate (6 mmol) was added and heated in a conical flask at 110-120 o C for 30 min, then the temperature was raised to 140-150 o C gradually over 30 min. After that the mixture was cooled to room temperature and kept in an ice-cold water bath for ca. 2 h. The Yellowish orange crystalline product was filtered and crystallized to give the compound 15.
Procedure B.
A mixture of acetohydrazide 3 (5 mmol) and triethyl orthoformate (15 mmol) was heated under reflux for 2 h. After that the mixture was cooled to room temperature and triturated with cold methanol (10 mL). The solid so formed was filtered off and crystallized to
give the compound 15.
2-{[2-Methyl-5-(methylthio)-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]oxy}-4H-pyrido[1,2-a]pyrimidin-4-one (17)
To a solution of the acetohydrazide 3 (5 mmol), in absolute ethanol (50mL), sodium ethoxide (15 mmol) was added, followed by drop-wise addition of carbon disulfide (5 mmol) with continuous stirring in and ice-cold water bath at 0-5 o C. After complete addition, the mixture was stirred at room temperature for 30 min and methyl iodide (20 mmol) was dropped over a period of ca. 20 min, then the reactor was fitted with reflux condenser and heated at boiling for 1h. After cooling, the crystalline deposits were collected by filtration, washed with cold ethanol and crystallized to afford the pyrazole 17. [
2-[(5-
Phenyl
5-{[(4-Oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)oxy]methyl}-1,3,4-oxadiazol-2(3H)-ylidene]malononitrile (20)
A mixture of the acetohydrazide 3 (15 mmol) and [bis(methylthio)methylene]-malononitrile (6 mmol), in DMF (20 mL) was heated under reflux till evolution of methanethiol ceased (ca. 1h). Then, the reaction solution was left to cool at room temperature and the crystalline precipitate so formed was filtered and crystallized to give the 1,3,4-oxadiazole 20.
